POINTER and LatAm-FINGERS studies, representing the next phase in advancing risk reduction and prevention strategies for Alzheimer's and other diseases that cause dementia
Gallagher EJ, Sun H, Kornhauser C, Tobin-Hess A, Epstein S, Yakar S, et al
However, their precise mechanisms of action remain under investigation
The MHRA determines whether a product is a medicine on a case-by-case basis
Pituitary GH release stimulates hepatic IGF-1 production, and circulating IGF-1 then mediates many tissue-level effects relevant to research
Ongoing efforts are made to strengthen domestic manufacturing infrastructure, promoting the indigenous manufacturing of GLP-1 drugs